Major EU funding set to make leukemia therapies safer

- EN - DE

Freiburg medical professional Robert Zeiser receives an ERC Advanced Grant

A stem cell donation is a promising therapy for many leukemia patients. But the therapy has risks: It is not uncommon for leukemia to return, and in about half of those treated, the transferred immune cells attack the recipient’s tissue. Such acute graft-versus-host disease, or aGvHD, is just as life-threatening as a possible leukemia relapse. ...

account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.